Management of Intracranial Tuberculous Mass Lesions: How Long Should We Treat For?

Wellcome Open Research - United Kingdom
doi 10.12688/wellcomeopenres.15501.1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

F1000 Research Ltd

Related search

How Should We Treat Early Post-Transplant Lymphoproliferative Disease After Heart Transplantation?

International Heart Journal
MedicineCardiovascular MedicineCardiology
2015English

How Should We Treat Post-Traumatic Stress Disorder in Active Military Personnel?

Expert Review of Neurotherapeutics
NeuroscienceNeurologyPharmacology
2017English

Bilateral Ovarian Tumors on MRI: How Should We Differentiate the Lesions?

Yonago Acta Medica
Medicine
2018English

How We Should Measure "Change": Or Should We?

Psychological Bulletin
Philosophy of SciencePsychologyHistory
1970English

How Should We Treat Alectinib-Refractory ALK-Positive Non–Small Cell Lung Cancer?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Pathogenesis of Unusual Intracranial Tuberculomas and Tuberculous Space-Occupying Lesions

Journal of Neurosurgery
SurgeryNeurology
1968English

Feasibility of Prehospital Treatment With Activated Charcoal: Who Could We Treat, Who Should We Treat?

Emergency Medicine Journal
MedicineCritical CareEmergency MedicineIntensive Care Medicine
2003English

How We Treat Germ Cell Cancers

Cancer
Cancer ResearchOncology
2017English

How We Diagnose and Treat Essential Thrombocythaemia

British Journal of Haematology
Hematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy